When Miralax Isn’t Enough: Updates in Constipation Treatment

We are pleased to offer this expert-led training module, When Miralax Isn’t Enough: Updates in Constipation Treatment,  presented by David Levinthal, MD, PhD, as part of our continuing education series aligned with the University of Pittsburgh Department of Medicine’s 2025 Update in Internal Medicine (UIM): Practice Changing Advances. This self-paced session delivers timely, evidence-based insights to support clinical decision-making and enhance patient care.

Target Audience

Physician, Advanced Practice Provider, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant, and Other Healthcare Professional.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply strategies to improve the efficiency of the initial diagnostic workup for patients presenting with constipation.
  • Evaluate the evidence supporting the use of currently available pharmacological agents for treating chronic constipation disorders.
  • Assess the need for pelvic floor disorder workup in patients who do not initially respond to dietary and over-the-counter laxative therapy to improve patient outcomes.
Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    • 1.00 Pharmacotherapeutic
  • 1.00 Attendance
Course opens: 
10/22/2025
Course expires: 
06/30/2026
Part of: 
Updates in Internal Medicine 2025: October 24 - PM Sessions

Presenter:

David Levinthal, MD, PhD
Associate Professor of Medicine
Director, Neurogastroenterology & Motility Center
Co-Director, UPMC Program for Gut Brain Health (PGH)
Department of Medicine
University of Pittsburgh

CONFLICT OF INTEREST DISCLOSURE

Dr. Levinthal is a consultant with Takeda Pharmaceuticals, Azurity Pharmaceuticals, Gemelli Biotech, and Enterra Medical.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

DISCLAIMER STATEMENT

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

image
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacotherapeutic/pharmacology content contained within each presentation has been calculated and designated in the course agenda. The total hours will be noted on your certificate. Click here for a specific list of the hours awarded for each presentation.  

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    • 1.00 Pharmacotherapeutic
  • 1.00 Attendance
Please login or register to take this course.